This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.


  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Apr. 5, 2012

   Home   Mission/Vision    Membership    Corporate Membership    CME/CEU    JMCM    Contact Us

Click Here to view the Journal of Managed Care Medicine

Online CME/CEU Programs
Multiple Myeloma: An Update on Diagnostic and Treatment Strategies

Advanced Treatment of Osteoporosis in Postmenopausal Women

Decreasing the Cost Burden of Fibromyalgia with Early Diagnosis and Management


Announcing the NAMCP Medical Directors Lung Cancer Resource Center. Click here to visit the website.

Be sure to check out the study results of Verinata's Non-Invasive Prenatal Technology. Click here to view the press release.

Click here to check out the "Latest in Clinical Nutrition" DVD available for purchase now!

 



 Genomics

Scientists: Your DNA blueprint may disappoint
msnbc    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A readout of all of your DNA? You'll get it soon. So what will this "genetic blueprint" tell us of our future health? Not much, according to an important study from a group of scientists at the Johns Hopkins University School of Medicine. More



Study: Fat gene may predict protection against diabetes
The Boston Globe    Share    Share on FacebookTwitterShare on LinkedinE-mail article
While obesity is a huge risk factor for type 2 diabetes, many people with 50 or 60 extra pounds to lose never develop the condition, and a new study provides a possible explanation. It may have something to do with how much they express a particular gene that makes cells more sensitive to insulin, which transports glucose into cells. More

Scientists identify genetic changes that may increase PTSD risk
TIME    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Natural disaster, violent crime and war are traumatic experiences for anyone to live through, yet some people recover quickly while others struggle with the flashbacks and hypervigilance that characterize post-traumatic stress disorder. Why? Scientists say they have pinpointed genetic changes that may make some people more vulnerable to PTSD than others. More

 Biotech/Diagnostics/Personalized Medicine


Breast cancer screening may over diagnose by up to 25 percent
Bloomberg    Share    Share on FacebookTwitterShare on LinkedinE-mail article
As many as 1 in 4 cancers picked up in routine breast screenings pose no threat to a woman's health, according to a study whose authors raise questions on whether screening programs should continue. Among almost 40,000 women diagnosed with invasive breast cancer, between 15 percent and 25 percent had tumors that wouldn't have progressed to a harmful degree, researchers wrote. More

Sleeping pills pose added death risk for obese patients
American Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The mortality rate for obese patients who regularly take sleeping pills is nine times higher than the death risk for similar patients who do not use the drugs, said a study presented at an American Heart Association meeting. Researchers examined medical records of more than 34,000 patients. Obese patients who took hypnotic medicines regularly were 9.3 times likelier to die than patients with similar health who did not. More


Introducing mySentry™ from Medtronic...

The world’s first remote glucose monitor designed to provide protection from overnight hypoglycemia. MORE
Our activities touch many lives
AstraZeneca is a global, innovation-driven, integrated biopharmaceutical company. We discover, develop, manufacture and market prescription medicines for cancer, cardiovascular, gastrointestinal and infection. MORE


 Regenerative Medicine


Stanford: Antibody offers hope against cancers
San Francisco Chronicle    Share    Share on FacebookTwitterShare on LinkedinE-mail article
In a potential breakthrough for cancer research, Stanford immunologists discovered they can shrink or even get rid of a wide range of human cancers by treating them with a single antibody. The experiments were done on cancerous tumors transplanted into mice, but researchers hope to move to human clinical trials within a couple of years. More



Stem cells hold clues for colon cancer
WIAT-TV    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A new study provides insight into where colon cancer may come from and possible therapeutic targets for the disease. A team of researchers are using a clinically engineered mouse model for colorectal cancer. Investigators can now use the mouse to better understand how and where colorectal cancer comes from. More

 Emerging Medical Technologies


New underwear limiting IED damage to troops
USA Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Without the armored shorts, nearly three in four troops who lost legs to bomb blasts also suffered genital injuries from February 2010 to February 2011, according to the Joint IED Defeat Organization. That dropped to less than half for troops wearing PUGs from February 2011 to last month. Two types of PUGs have been fielded to troops by the Army. The shorts keep dirt and fine debris from bomb blasts from piercing the skin. A protective cup shields troops from larger fragments. More

Homemade tricorders and handheld healthcare
The Washington Post    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The tricorder. Beloved by nearly every science fiction fan, the handheld scanner and data analysis device featured throughout the fictional "Star Trek" universe was among many that served to prime society for the smartphone, the tablet and other digital handheld tools and toys. The interface is so popular there's even an app for it. More

 Managed Healthcare News


Study: Cancer care pricier at hospital than doctor's office
The Washington Post    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Not all healthcare cost variation has to do with geography: It turns out that what kind of facility you seek treatment at matters a lot, too. An episode of cancer treatment costs 24 percent more at a hospital than if the same course of treatment were carried out at a doctor's office, according to a new analysis from Avalere Health. More

Details emerge on Ohio's health plan
The Associated Press via Houston Chronicle    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Ohio's plan to streamline medical care for some of its sickest, most expensive and difficult to treat patients includes changes designed to eliminate unnecessary health tests, prevent medication errors and keep people healthier and out of emergency rooms. The proposal for those enrolled in Medicaid and Medicare could be a model for other states, said Ohio officials who drafted the plan. More

 FDA: New Treatments and Technology


FDA finds new batch of counterfeit Avastin cancer drug
The Wall Street Journal    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The Food and Drug Administration has found a new batch of counterfeit Avastin apparently distributed by a different network from the one connected to an earlier fake supply of the cancer drug. The newly uncovered fakes were packaged in boxes labeled as Altuzan, the brand name for Avastin in Turkey, the FDA said. More

FDA staff focus on safety of bladder drug
Reuters    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Drug reviewers said Astellas Pharma's treatment for an overactive bladder worked, but they raised concerns about liver and heart safety issues. The Food and Drug Administration staff said the once-daily tablet, called mirabegron, worked to reduce frequent urination and the inability to control it, according to documents. More

FAST FACTS
"Post-traumatic stress disorder can afflict people of any age; an average age of onset is 23. It can be triggered by physical and sexual abuse, accidents, war and military service and many other events, according to the National Institute of Mental Health."
 
Genomics Biotech and Emerging Medical Technologies Institute eBrief
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Christine Kraly, Content Editor, 469.420.2685   
Contribute news

This edition of the Genomics Biotech and Emerging Medical Technologies Institute eBrief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
March 29, 2012
March 22, 2012
March 15, 2012
March 8, 2012



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063